Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Accurate personalized survival prediction for amyotrophic lateral sclerosis patients ; volume:13 ; number:1 ; day:24 ; month:11 ; year:2023 ; pages:1-7 ; date:12.2023
Scientific reports ; 13, Heft 1 (24.11.2023), 1-7, 12.2023
- Urheber
-
Kuan, Li-Hao
Parnianpour, Pedram
Kushol, Rafsanjany
Kumar, Neeraj
Anand, Tanushka
Kalra, Sanjay
Greiner, Russell
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-47935-7
- URN
-
urn:nbn:de:101:1-2024020714443833405700
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuan, Li-Hao
- Parnianpour, Pedram
- Kushol, Rafsanjany
- Kumar, Neeraj
- Anand, Tanushka
- Kalra, Sanjay
- Greiner, Russell
- SpringerLink (Online service)
Ähnliche Objekte (12)
Equipoise Is a Slippery Eel
Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
Discrimination and diabetes: Insight from the second Diabetes Attitudes Wishes and Needs (DAWN2) Study
Mishti copes with diabetes: A pragmatic approach to coping skills training
Therapy in type 2 diabetes: A logical empiricism - based approach
Higher, sweeter, heavier: Not necessarily healthier
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Mishti copes with diabetes: Dancing
Diabetes: Exploring social and psychological domain
The alcohol and tobacco burden of India
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Equipoise Is a Slippery Eel
Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
Discrimination and diabetes: Insight from the second Diabetes Attitudes Wishes and Needs (DAWN2) Study
Mishti copes with diabetes: A pragmatic approach to coping skills training
Therapy in type 2 diabetes: A logical empiricism - based approach
Higher, sweeter, heavier: Not necessarily healthier
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Mishti copes with diabetes: Dancing
Diabetes: Exploring social and psychological domain
The alcohol and tobacco burden of India
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Equipoise Is a Slippery Eel
Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
Discrimination and diabetes: Insight from the second Diabetes Attitudes Wishes and Needs (DAWN2) Study
Mishti copes with diabetes: A pragmatic approach to coping skills training
Therapy in type 2 diabetes: A logical empiricism - based approach
Higher, sweeter, heavier: Not necessarily healthier
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Mishti copes with diabetes: Dancing
Diabetes: Exploring social and psychological domain
The alcohol and tobacco burden of India
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes